CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary
Sahajanand Medical Technologies Limited 路 Others (Uncategorized) 路 04 Nov 2026, 9:19 pm
CRISIL Upgrades Credit Ratings for Sahajanand Medical Technologies and Subsidiary CRISIL Ratings has upgraded Sahajanand Medical Technologies Ltd's bank facilities rating to 'CRISIL A-/Stable/CRISIL A2+' from 'CRISIL BBB+/Stable/CRISIL A2', enhancing rated limits to Rs 300 crore. Subsidiary SMT Cardiovascular's rating was upgraded to 'CRISIL BBB+/Stable' from 'CRISIL BBB/Stable'. The upgrade reflects a strengthened business risk profile following an 18% YoY operating revenue increase to Rs 1,214.14 crore and a PAT surge to Rs 69.08 crore in FY26, supported by stable operating margins (13.14%) and a healthy capital structure with gearing at 0.43x.
Original exchange filing (PDF)
More announcements from Sahajanand Medical Technologies Limited
- Schedule of Analyst/Investor Meet 路 11 Nov 2026
- Transcript of Earnings Call for Q2 & H1 FY27 Financial Results held on Thursday, November 05, 2026. 路 08 Nov 2026
- As per SEBI(LODR) Regulations, 2015- submission of audio recording of Earnings call held on 05 November 2026 路 06 Nov 2026
- The Board of Directors of the Company at it Meeting held today has approved appointment of M/s. Amit Jaste & Associates, Company Secretaries as Secretarial Auditor of the Company. 路 06 Nov 2026
- Dear Sir/Ma''am- The Board of Directors of the Company has approved investment by wholly owned subsidiary company in SNP Medical Corp. 路 05 Nov 2026
- Dear Sir/Ma''am- please find enclosed Investor presentation for wider circulation to general public. 路 05 Nov 2026
- Outcome of the Board Meeting dated November 5, 2026 路 05 Nov 2026
- Results- Unaudited financial Results for the period ended 30th September 2026 路 05 Nov 2026
